← Back to Search

Diagnostic Device

Investigational Ultrasound Imaging for Liver Fat Quantification for Non-alcoholic Fatty Liver Disease

N/A

Waitlist Available

Led By Smita S Bailey, MD

Research Sponsored by Philips Clinical & Medical Affairs Global

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up intra-procedural (1 day)

Awards & highlights

Study Summary

This study is evaluating whether a new ultrasound technique can help detect liver fat.

Eligible Conditions

Non-alcoholic Fatty Liver Disease

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ intra-procedural (1 day)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~intra-procedural (1 day)

This trial's timeline: 3 weeks for screening, Varies for treatment, and intra-procedural (1 day) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Correlation of the liver fat percentage reported from MRI-PDFF with measurements of ultrasound biomarkers for liver fat.

Secondary outcome measures

Inter-operator variability in measurements of ultrasound biomarkers for liver fat

Ultrasound biomarker measurement failure rate

Trial Design

1Treatment groups

Experimental Treatment

Group I: Investigational Ultrasound Imaging for Liver Fat QuantificationExperimental Treatment1 Intervention

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Investigational Liver Fat Quantification Software

2020

N/A

~100

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Philips Clinical & Medical Affairs GlobalLead Sponsor

50 Previous Clinical Trials

16,544 Total Patients Enrolled

1 Trials studying Non-alcoholic Fatty Liver Disease

63 Patients Enrolled for Non-alcoholic Fatty Liver Disease

Smita S Bailey, MDPrincipal InvestigatorPhoenix Children's Hospital

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Could you please provide an estimate of the total number of participants in this medical experiment?

"Affirmative. The information posted on clinicaltrials.gov illustrates that this trial, which was initially published on the 2nd of March 2021, is currently recruiting participants. 30 individuals are required to be enrolled across a single medical centre."

Answered by AI

Does this research initiative accept elderly participants?

"To be accepted into this medical study, the patient must fall between 5 and 21 years of age. There are 33 trials for those younger than 18, with 319 available to individuals 65 or older."

Answered by AI

To whom does the criteria for participation in this clinical trial apply?

"The requirements for this medical trial stipulate that participants should have a liver illness and be aged between 5 and 21 years old. In total, the study is looking to include 30 people in its experiments."

Answered by AI

Are recruitment efforts underway for this medical experiment?

"Correct. The clinical trial registry on clinicaltrials.gov states that this study was first posted on March 2nd 2021 and is currently seeking up to 30 individuals at one medical centre."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Pediatric Liver Fat Quantification (LFQ) Phase 2 Pilot Study

2021. "Pediatric Liver Fat Quantification (LFQ) Phase 2 Pilot Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04800094.